AG
MGRX icon

AmeriFlex Group’s Mangoceuticals MGRX Stock Holding History

AmeriFlex Group’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1K Buy
+2,885
New +$1.11K ﹤0.01% 1399

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.47B AUM 24.93% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AmeriFlex Group's MGRX Position: Q2 2026 in Review

AmeriFlex Group opened a new position in Mangoceuticals (MGRX) in Q2 2026: 2,885 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #1399 among its holdings.

12 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • AmeriFlex Group held 2,885 shares of Mangoceuticals worth $1.1K as of Q2 2026.
  • Mangoceuticals was a new AmeriFlex Group position in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1399 holding.
  • 12 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.